FENC FENNEC PHARMACEUTICALS INC.
Nasdaq · SEC CIK 1211583 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $12.65M 21 sales by 8 insiders
- Filings on record
- 209 since 2021-07-01, latest 2026-09-16 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Southpoint Capital Advisors LP | 10% | — | $7.50M |
| Southpoint GP, LLC | 10% | — | $2.04M |
| Raykov Rosty | Former Dir | — | $1.05M |
| Andrade Robert | CFO | — | $883.5K |
| Southpoint Capital Advisors LLC | 10% | — | $806.3K |
| Brughera Marco Maria | Dir | — | $160.0K |
| Sayad Pierre Sargis | Chief Medical Off | — | $146.2K |
| RALLIS CHRIS A | Dir | — | $75.2K |
| Cioffi Christiana Marie | Chief Strategy Off | — | — |
| Evans Terry L | Chief Commercial Off | — | — |
Transactions 209
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-02 | 2025-05-31 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +5,208 | 75.5K | +7% | $0 | |
| 2025-06-02 | 2025-05-31 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +2,431 | 161.0K | +2% | $0 | |
| D | 2025-05-23 | 2025-05-22 | FENC | Andrade Robert | CFO | M - OptEx | $5.10 | +8,220 | 158.5K | +5% | +$41.9K |
| 2025-05-19 | 2025-05-16 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +16.7K | 150.3K | +12% | $0 | |
| 2025-05-19 | 2025-05-16 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +33.3K | 86.9K | +62% | $0 | |
| 2025-05-19 | 2025-05-16 | FENC | Raykov Rosty | Dir | S - Sale | $6.78 | -16.7K | 70.3K | -19% | -$113.0K | |
| M | 2025-05-19 | 2025-05-16+ | FENC | Hackman Jeffrey S. | CEO, Dir | P - Purchase | $6.97 | +15.0K | 15.0K | New | +$104.6K |
| 2025-05-05 | 2025-05-05 | FENC | Raykov Rosty | Dir | S - Sale | $6.31 | -10.0K | 53.6K | -16% | -$63.1K | |
| 2025-05-01 | 2025-04-30 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,042 | 133.6K | +0.8% | $0 | |
| 2025-05-01 | 2025-04-30 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +2,431 | 63.6K | +4% | $0 | |
| D | 2025-04-11 | 2025-04-11 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $4.95 | -1,409 | 53.8K | -3% | -$6,975 |
| D | 2025-04-11 | 2025-04-11 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.30 | +2,173 | 55.2K | +4% | +$4,998 |
| 2025-04-04 | 2025-04-04 | FENC | Raykov Rosty | Dir | S - Sale | $5.25 | -10.0K | 61.2K | -14% | -$52.5K | |
| 2025-04-01 | 2025-03-31 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +2,431 | 71.2K | +4% | $0 | |
| 2025-04-01 | 2025-03-31 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,042 | 132.6K | +0.8% | $0 | |
| 2025-03-06 | 2025-03-05 | FENC | Raykov Rosty | Dir | S - Sale | $6.79 | -10.0K | 68.7K | -13% | -$67.9K | |
| 2025-02-28 | 2025-02-28 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +2,431 | 78.7K | +3% | $0 | |
| 2025-02-28 | 2025-02-28 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,042 | 131.5K | +0.8% | $0 | |
| D | 2025-02-14 | 2025-02-14 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $6.82 | -1,186 | 53.0K | -2% | -$8,089 |
| D | 2025-02-14 | 2025-02-14 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.51 | +1,992 | 54.2K | +4% | +$5,000 |
| 2025-02-05 | 2025-02-05 | FENC | Raykov Rosty | Dir | S - Sale | $6.66 | -10.0K | 76.3K | -12% | -$66.6K | |
| 2025-02-03 | 2025-01-31 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,042 | 130.5K | +0.8% | $0 | |
| 2025-02-03 | 2025-01-31 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +2,431 | 86.3K | +3% | $0 | |
| M | 2025-01-07 | 2025-01-06 | FENC | Raykov Rosty | Dir | S - Sale | $6.08 | -10.0K | 83.9K | -11% | -$60.8K |
| 2025-01-03 | 2024-12-31 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +2,431 | 93.9K | +3% | $0 | |
| 2025-01-03 | 2024-12-31 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,042 | 129.5K | +0.8% | $0 | |
| D | 2024-12-23 | 2024-12-20 | FENC | Raykov Rosty | Dir | M - OptEx | $2.69 | +25.0K | 91.4K | +38% | +$67.2K |
| 2024-12-05 | 2024-12-05 | FENC | Raykov Rosty | Dir | S - Sale | $6.04 | -796 | 66.4K | -1% | -$4,808 | |
| 2024-12-04 | 2024-12-03 | FENC | Raykov Rosty | Dir | S - Sale | $6.13 | -1,635 | 67.2K | -2% | -$10.0K | |
| 2024-12-04 | 2024-12-02 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +2,431 | 68.9K | +4% | $0 | |
| 2024-12-02 | 2024-12-02 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,042 | 128.4K | +0.8% | $0 | |
| D | 2024-12-02 | 2024-12-02 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $6.14 | -6,409 | 52.2K | -11% | -$39.4K |
| D | 2024-12-02 | 2024-12-02 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.69 | +10.0K | 58.6K | +21% | +$26.9K |
| D | 2024-11-18 | 2024-11-18 | FENC | Andrade Robert | CFO | M - OptEx | $2.45 | +15.8K | 127.4K | +14% | +$38.7K |
| 2024-11-04 | 2024-10-31 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,042 | 111.6K | +0.9% | $0 | |
| 2024-11-04 | 2024-11-04 | FENC | Raykov Rosty | Dir | S - Sale | $4.31 | -2,431 | 66.4K | -4% | -$10.5K | |
| 2024-11-04 | 2024-10-31 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +2,431 | 68.9K | +4% | $0 | |
| D | 2024-10-10 | 2024-10-08 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $4.53 | -1,406 | 48.6K | -3% | -$6,369 |
| D | 2024-10-10 | 2024-10-08 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.55 | +1,960 | 50.0K | +4% | +$4,998 |
| 2024-10-01 | 2024-09-30 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +2,431 | 68.9K | +4% | $0 | |
| 2024-10-01 | 2024-10-01 | FENC | Raykov Rosty | Dir | S - Sale | $4.94 | -2,431 | 66.4K | -4% | -$12.0K | |
| 2024-10-01 | 2024-09-30 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,042 | 110.5K | +1.0% | $0 | |
| 2024-09-04 | 2024-08-31 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +2,431 | 68.9K | +4% | $0 | |
| 2024-09-04 | 2024-09-04 | FENC | Raykov Rosty | Dir | S - Sale | $5.52 | -2,431 | 66.4K | -4% | -$13.4K | |
| 2024-09-04 | 2024-08-31 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,042 | 109.5K | +1.0% | $0 | |
| MA | 2024-08-27 | 2024-08-23 | FENC | Raykov Rosty | Dir | G - Gift | $0.00 | -121.0K | 120.8K | -50% | $0 |
| M | 2024-08-26 | 2024-08-23 | FENC | Raykov Rosty | Dir | G - Gift | $0.00 | -95.0K | 120.8K | -44% | $0 |
| 2024-08-01 | 2024-07-31 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,042 | 108.4K | +1.0% | $0 | |
| 2024-08-01 | 2024-07-31 | FENC | Raykov Rosty | CEO, Dir | A - Grant | $0.00 | +2,431 | 189.9K | +1% | $0 | |
| 2024-08-01 | 2024-08-01 | FENC | Raykov Rosty | CEO, Dir | S - Sale | $6.26 | -2,431 | 187.5K | -1% | -$15.2K | |
| D | 2024-07-08 | 2024-07-05 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.79 | +1,792 | 47.6K | +4% | +$5,000 |
| D | 2024-07-08 | 2024-07-05 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $6.03 | -1,173 | 46.5K | -2% | -$7,073 |
| 2024-07-02 | 2024-07-01 | FENC | Raykov Rosty | CEO, Dir | A - Grant | $0.00 | +2,431 | 189.9K | +1% | $0 | |
| 2024-07-02 | 2024-07-02 | FENC | Raykov Rosty | CEO, Dir | S - Sale | $6.13 | -2,431 | 187.5K | -1% | -$14.9K | |
| 2024-07-02 | 2024-07-01 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,042 | 107.4K | +1.0% | $0 | |
| 2024-06-03 | 2024-05-31 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,042 | 106.4K | +1.0% | $0 | |
| 2024-06-03 | 2024-06-03 | FENC | Raykov Rosty | CEO, Dir | S - Sale | $6.76 | -2,431 | 187.5K | -1% | -$16.4K | |
| 2024-06-03 | 2024-05-31 | FENC | Raykov Rosty | CEO, Dir | A - Grant | $0.00 | +2,431 | 189.9K | +1% | $0 | |
| 2024-05-02 | 2024-04-30 | FENC | Raykov Rosty | CEO, Dir | A - Grant | $0.00 | +2,431 | 189.9K | +1% | $0 | |
| 2024-05-02 | 2024-05-01 | FENC | Raykov Rosty | CEO, Dir | S - Sale | $9.11 | -2,431 | 187.5K | -1% | -$22.1K | |
| 2024-05-02 | 2024-04-30 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,042 | 105.3K | +1.0% | $0 | |
| MA | 2024-04-26 | 2024-04-17+ | FENC | Haigh Adrian | COO | M - OptEx | $2.31 | +44.4K | 44.4K | New | +$102.7K |
| MA | 2024-04-26 | 2024-04-15+ | FENC | Haigh Adrian | COO | M - OptEx | $2.31 | +44.4K | 44.4K | New | +$102.7K |
| DM | 2024-04-22 | 2024-04-19+ | FENC | Haigh Adrian | COO | S - Sale+OE | $9.33 | -44.4K | 0 | -100% | -$414.7K |
| DM | 2024-04-22 | 2024-04-19+ | FENC | Haigh Adrian | COO | M - OptEx | $2.31 | +44.4K | 22.2K | New | +$102.7K |
| DM | 2024-04-18 | 2024-04-17+ | FENC | Haigh Adrian | COO | S - Sale | $6.04 | 0 | 44.4K | New | $0 |
| DM | 2024-04-16 | 2024-04-15+ | FENC | Haigh Adrian | COO | S - Sale | $6.30 | 0 | 0 | New | $0 |
| D | 2024-04-15 | 2024-04-15 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $10.45 | -800 | 44.4K | -2% | -$8,360 |
| D | 2024-04-15 | 2024-04-15 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $10.45 | +1,389 | 45.8K | +3% | +$14.5K |
| M | 2024-04-05 | 2024-04-04+ | FENC | Raykov Rosty | CEO, Dir | S - Sale | $10.82 | -88.6K | 231.8K | -28% | -$958.5K |
| M | 2024-04-03 | 2024-04-03 | FENC | Raykov Rosty | CEO, Dir | S - Sale | $10.78 | -40.6K | 302.1K | -12% | -$437.5K |
| 2024-04-03 | 2024-04-01 | FENC | Raykov Rosty | CEO, Dir | P - Purchase | $0.00 | +29.2K | 316.6K | +10% | $0 | |
| 2024-04-03 | 2024-04-01 | FENC | Andrade Robert | CFO | P - Purchase | $0.00 | +12.5K | 104.3K | +14% | $0 | |
| 2024-03-27 | 2024-03-26 | FENC | Andrade Robert | CFO | S - Sale | $10.90 | -14.0K | 91.8K | -13% | -$152.3K | |
| D | 2024-03-27 | 2024-03-26 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $10.97 | -2,114 | 40.9K | -5% | -$23.2K |
| D | 2024-03-27 | 2024-03-26 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.31 | +4,329 | 45.2K | +11% | +$10,000 |
| 2024-03-25 | 2024-03-25 | FENC | Andrade Robert | CFO | S - Sale | $11.00 | -14.0K | 105.7K | -12% | -$153.7K | |
| M | 2024-01-05 | 2024-01-04+ | FENC | Andrade Robert | CFO | S - Sale | $10.53 | -30.0K | 134.7K | -18% | -$315.8K |
| D | 2023-12-29 | 2023-12-28 | FENC | Raykov Rosty | CEO, Dir | M - OptEx | $1.59 | +8,540 | 291.1K | +3% | +$13.6K |
| D | 2023-12-29 | 2023-12-28 | FENC | Raykov Rosty | CEO, Dir | S - Sale+OE | $11.55 | -3,656 | 287.5K | -1% | -$42.2K |
| D | 2023-12-28 | 2023-12-26 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $10.90 | -1,390 | 44.8K | -3% | -$15.2K |
| D | 2023-12-28 | 2023-12-26 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $1.59 | +3,144 | 46.2K | +7% | +$4,999 |
| 2023-11-20 | 2023-11-20 | FENC | RALLIS CHRIS A | Dir | S - Sale | $8.25 | -269 | 43.0K | -0.6% | -$2,219 | |
| DM | 2023-11-16 | 2023-11-16 | FENC | Islam Khalid | Dir | M - OptEx | $2.06 | +213.8K | 133.3K | New | +$441.4K |
| M | 2023-11-09 | 2023-11-08 | FENC | Raykov Rosty | CEO, Dir | S - Sale | $7.76 | -25.0K | 290.6K | -8% | -$194.3K |
| D | 2023-11-03 | 2023-11-03 | FENC | Raykov Rosty | CEO, Dir | M - OptEx | $1.59 | +74.8K | 307.6K | +32% | +$118.9K |
| 2023-08-18 | 2023-08-18 | FENC | RALLIS CHRIS A | Dir | S - Sale | $7.85 | -673 | 43.3K | -2% | -$5,283 | |
| D | 2023-07-24 | 2023-07-24 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $0.72 | +16.7K | 50.8K | +49% | +$12.0K |
| D | 2023-07-24 | 2023-07-24 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $8.17 | -6,796 | 44.0K | -13% | -$55.5K |
| D | 2023-07-06 | 2023-07-06 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $0.96 | +5,280 | 34.1K | +18% | +$5,069 |
| D | 2023-07-06 | 2023-07-06 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $8.47 | -2,207 | 28.8K | -7% | -$18.7K |
| DM | 2023-06-30 | 2023-06-28+ | FENC | Andrade Robert | CFO | S - Sale+OE | $8.93 | -25.0K | 124.7K | -17% | -$223.3K |
| D | 2023-06-30 | 2023-06-30 | FENC | Andrade Robert | CFO | M - OptEx | $2.45 | +25.0K | 149.7K | +20% | +$61.3K |
| M | 2023-05-19 | 2023-05-19 | FENC | RALLIS CHRIS A | Dir | S - Sale | $7.36 | -1,758 | 31.0K | -5% | -$12.9K |
| 2023-04-17 | 2023-04-17 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.94 | +1,700 | 33.8K | +5% | +$4,998 | |
| 2023-04-17 | 2023-04-17 | FENC | RALLIS CHRIS A | Dir | F - Tax | $8.34 | -986 | 32.8K | -3% | -$8,223 | |
| 2023-03-03 | 2023-03-03 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.40 | +4,166 | 34.2K | +14% | +$9,998 | |
| 2023-03-03 | 2023-03-03 | FENC | RALLIS CHRIS A | Dir | F - Tax | $9.09 | -2,177 | 32.1K | -6% | -$19.8K | |
| M | 2022-12-30 | 2022-12-28+ | FENC | Raykov Rosty | CEO, Dir | S - Sale | $9.61 | -28.7K | 232.8K | -11% | -$276.2K |
| M | 2022-12-30 | 2022-12-28+ | FENC | Andrade Robert | CFO | S - Sale | $9.60 | -22.0K | 160.7K | -12% | -$211.2K |
Purchase Sale Sale after option exercise All abbreviations